Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-11-15 | TScan Therapeutics, Inc. | Nichols Weston
(AtLeastTenPercentOwner) |
P | Common stock, $0.0001 par value per share | A | 947 | $4.34 - $4.34 | $4,113 |
2024-09-23 | TScan Therapeutics, Inc. | Klencke Barbara
(Director) |
P | Voting Common Stock | A | 5000 | $5.29 - $5.29 | $26,450 |
2024-08-23 | TScan Therapeutics, Inc. | Klencke Barbara
(Director) |
P | Voting Common Stock | A | 10000 | $5.53 - $5.69 | $56,100 |
2024-08-23 | TScan Therapeutics, Inc. | ZDRAVESKI ZORAN
(See Remarks) |
S | Voting Common Stock | D | 164686 | $5.78 - $5.78 | $952,115 |
2024-08-23 | TScan Therapeutics, Inc. | ZDRAVESKI ZORAN
(See Remarks) |
M | Voting Common Stock | A | 157186 | $1.81 - $4.85 | $531,519 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |